Swine flu will give drugs giant GlaxoSmithKline a £2.6bn boost

swine_drugsGlaxoSmithKline could reap a £2.6billion windfall from the swine flu pandemic, it emerged yesterday.

Sales of the drugs giant’s Relenza inhaler, used to treat the symptoms of the virus, are expected to top £600million, bossAndrew Wittyconfirmed.

And this figure could be boosted by a further £1billion-£2billion once deliveries of vaccination for the H1N1 strain of the bug begin in September, according to analysts.

Read more:http://www.dailymail.co.uk/money/article-1201491/Swine-flu-pandemic-drugs-giant-GlaxoSmithKline-2-6bn-boost.html?ITO=1490#ixzz0MXbXPPTX

Related posts:

  1. Md. Reports Fourth Swine Flu Death, Eighth in Region
  2. Swine Flu Death Toll 816: WHO
  3. How to: Save a heart attack victim

Leave a Reply

Google Ads
Top Choices
  • Glasses
  • Laser eye surgery Perth
  • Physiotherapy Markham
  • Short Term Health Insurance
  • Supplements store
See More
  • Feather Hair Extensions
  • Grants for Single Mothers
  • Muscle Pharm Bullet Proof
  • Neck Cream
  • Printable Coupons Online
  • Fitness Online
  • Health.com
  • Natural News
  • WHO | World Health Organization